600056 中国医药
2024/06 - 中期
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
2020/12
人民币(K¥)
经营活动产生之现金流量净额(686,138)859,0751,645,872148,4211,559,305
投资活动产生之现金流量净额(200,013)(316,247)22,139(254,455)(328,140)
筹资活动产生之现金流量净额221,472(725,654)(2,024)(729,189)(365,675)
汇率变动对现金及现金等价物的影响3222,04110,742(4,054)(9,976)
现金及现金等价物净增加/(减少)(664,357)(180,785)1,676,730(839,277)855,513
期初现金及现金等价物余额3,330,2593,511,0441,834,3142,673,5911,818,078
期末现金及现金等价物余额2,665,9023,330,2593,511,0441,834,3142,673,591